EFZ
(-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE
Created: | 2000-08-15 |
Last modified: | 2020-06-05 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 30 |
Chiral Atom Count | 1 |
Bond Count | 32 |
Aromatic Bond Count | 6 |
Chemical Component Summary | |
---|---|
Name | (-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE |
Synonyms | DMP-266; Efavirenz |
Systematic Name (OpenEye OEToolkits) | (4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one |
Formula | C14 H9 Cl F3 N O2 |
Molecular Weight | 315.675 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | FC(F)(F)C3(C#CC1CC1)OC(=O)Nc2c3cc(Cl)cc2 |
SMILES | CACTVS | 3.370 | FC(F)(F)[C]1(OC(=O)Nc2ccc(Cl)cc12)C#CC3CC3 |
SMILES | OpenEye OEToolkits | 1.7.6 | c1cc2c(cc1Cl)C(OC(=O)N2)(C#CC3CC3)C(F)(F)F |
Canonical SMILES | CACTVS | 3.370 | FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC3CC3 |
Canonical SMILES | OpenEye OEToolkits | 1.7.6 | c1cc2c(cc1Cl)[C@@](OC(=O)N2)(C#CC3CC3)C(F)(F)F |
InChI | InChI | 1.03 | InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1 |
InChIKey | InChI | 1.03 | XPOQHMRABVBWPR-ZDUSSCGKSA-N |
Drug Info: DrugBank
DrugBank ID | DB00625 |
---|---|
Name | Efavirenz |
Groups |
|
Description | Efavirenz (brand names Sustiva® and Stocrin®) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1. For HIV infection that has not previously been treated, efavirenz and lamivudine in combination with zidovudine or tenofovir is the preferred NNRTI-based regimen. Efavirenz is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to prevent HIV transmission for those exposed to materials associated with a high risk for HIV transmission. |
Synonyms |
|
Brand Names |
|
Indication | For use in combination treatment of HIV infection (AIDS) |
Categories |
|
ATC-Code |
|
CAS number | 154598-52-4 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Gag-Pol polyprotein | MGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGL... | unknown | modulator |
Reverse transcriptase/RNaseH | PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI... | unknown | inhibitor |
Cytochrome P450 2C19 | MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV... | unknown | inducer |
Cytochrome P450 2C9 | MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI... | unknown | inhibitor |
Cytochrome P450 2B6 | MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRG... | unknown | substrate,inducer |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL223228 |
PubChem | 64139 |
ChEMBL | CHEMBL223228 |
ChEBI | CHEBI:119486 |
CCDC/CSD | KUVYUW, HUDRAC, AJEYAQ01, QUSREC, AJEYAQ03, XICSAF, QUSREC01 |